{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:32:06Z","timestamp":1771918326718,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ayurveda and Integrative Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jaim.2025.101181","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:32:12Z","timestamp":1765413132000},"page":"101181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of standalone personalized Ayurveda management in moderating functional index, inflammatory markers &amp; radiological progression in Ankylosing Spondylitis with 12 years follow up \u2013 A case report"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8897-1976","authenticated-orcid":false,"given":"Somit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavitha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7054-8993","authenticated-orcid":false,"given":"Santhi","family":"Krishna A S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaim.2025.101181_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1759720X18773726","article-title":"Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria","volume":"10","author":"Proft","year":"2018","journal-title":"Therapeutic Advances in Musculoskeletal disease"},{"key":"10.1016\/j.jaim.2025.101181_bib2","first-page":"21","article-title":"Early diagnosis crucial in ankylosing spondylitis","volume":"255","author":"Malaviya","year":"2011","journal-title":"Practitioner"},{"key":"10.1016\/j.jaim.2025.101181_bib3","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.3390\/ijms21176401","article-title":"The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis","volume":"21","author":"Tsukazaki","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.jaim.2025.101181_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/kep393","article-title":"Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs\/coxibs' treatment effect on C-reactive protein","volume":"49","author":"Benhamou","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaim.2025.101181_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211946","article-title":"Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: results of a community-based prospective study","volume":"14","author":"Su","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaim.2025.101181_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jmv.26085","article-title":"Elevated interleukin\u20106 is associated with severity of COVID\u201019: a meta\u2010analysis","volume":"93","author":"Zhu","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaim.2025.101181_bib7","first-page":"983","article-title":"Charaka samhita","volume":"vol. 2","author":"Tripathi","year":"2011"},{"key":"10.1016\/j.jaim.2025.101181_bib8","first-page":"545","article-title":"Ashtanga Hridaya","volume":"vol. 1","author":"Tripathi","year":"2011"},{"key":"10.1016\/j.jaim.2025.101181_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572912","article-title":"Antibiotics as major disruptors of gut microbiota","volume":"10","author":"Ramirez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jaim.2025.101181_bib10","series-title":"Nidana sthana","first-page":"513","article-title":"Commentaries Sarvangasundara of Arunadatta and Ayurvedarasayana of Hemadri on Astangahrudaya of Vagbhata","author":"Sharma","year":"2010"},{"key":"10.1016\/j.jaim.2025.101181_bib11","doi-asserted-by":"crossref","first-page":"rkab063","DOI":"10.1093\/rap\/rkab063","article-title":"\u2018All disease begins in the gut\u2019\u2014the role of the intestinal microbiome in ankylosing spondylitis","volume":"5","author":"Harkins","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.jaim.2025.101181_bib12","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaim.2025.101181_bib13","series-title":"Susrutha samhitha of Susrutha. Sutrasthana, Varnasi","first-page":"251","author":"Trikamji","year":"2012"},{"key":"10.1016\/j.jaim.2025.101181_bib14","series-title":"Chikitsa sthana","first-page":"512","article-title":"Charaka samhitha of Charaka","author":"Trikamji","year":"1992"},{"key":"10.1016\/j.jaim.2025.101181_bib15","first-page":"226","volume":"vol. 1","author":"Madhavakara","year":"2002"},{"key":"10.1016\/j.jaim.2025.101181_bib16","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00296-017-3801-7","article-title":"Posttraumatic stress disorder and correlates of disease activity among veterans with ankylosing spondylitis","volume":"37","author":"Liew","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaim.2025.101181_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpsychires.2017.01.007","article-title":"Elevated C-reactive protein and posttraumatic stress pathology among survivors of the 9\/11 World Trade Center attacks","volume":"89","author":"Rosen","year":"2017","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jaim.2025.101181_bib18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","article-title":"Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study","volume":"76","author":"Van Der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaim.2025.101181_bib19","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","article-title":"Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Van Der Heijde","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaim.2025.101181_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/ard.2007.072652","article-title":"A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis","volume":"67","author":"Ravindran","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaim.2025.101181_bib21","article-title":"The history of ankylosing spondylitis\/axial spondyloarthritis \u2013 what is the driving force of new knowledge","author":"Braun","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaim.2025.101181_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","article-title":"Ankylosing spondylitis: etiology, pathogenesis, and treatments","volume":"7","author":"Zhu","year":"2019","journal-title":"Bone Res"},{"key":"10.1016\/j.jaim.2025.101181_bib23","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00296-022-05174-5","article-title":"The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease","volume":"42","author":"Kenyon","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaim.2025.101181_bib24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3899\/jrheum.170166","article-title":"Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: data from a Swiss cohort","volume":"45","author":"Hebeisen","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaim.2025.101181_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/03009742.2021.1967046","article-title":"Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study","volume":"51","author":"Rusman","year":"2022","journal-title":"Scand J Rheumatol"}],"container-title":["Journal of Ayurveda and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947625000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0975947625000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:51:58Z","timestamp":1771905118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0975947625000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0975947625000579"],"URL":"https:\/\/doi.org\/10.1016\/j.jaim.2025.101181","relation":{},"ISSN":["0975-9476"],"issn-type":[{"value":"0975-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of standalone personalized Ayurveda management in moderating functional index, inflammatory markers & radiological progression in Ankylosing Spondylitis with 12 years follow up \u2013 A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Ayurveda and Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaim.2025.101181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Institute of Transdisciplinary Health Science and Technology and World Ayurveda Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101181"}}